You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 127 No. 6, June 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  OBSERVATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (74)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

T-Cell Subsets in Drug-Induced Toxic Epidermal Necrolysis

Possible Pathogenic Mechanism Induced by CD8-Positive T Cells

Hiroko Miyauchi, MD; Hiroshi Hosokawa, MD; Tamiyo Akaeda, MD; Hitoki Iba, MD; Yasuo Asada, MD

Arch Dermatol. 1991;127(6):851-855.


Abstract

• A patient with bromisovalum-induced toxic epidermal necrolysis showed pronounced delayed hypersensitivity to bromisovalum by patch testing. Biopsy specimens from the cutaneous lesion and the site of the positive patch test reaction were analyzed and compared immunohistologically. The findings were similar: most of the mononuclear cells disposed along the dermoepidermal junction and migrating into the epidermis were CD8-positive lymphocytes, whereas the dermal inflammatory infiltrates were composed predominantly of CD4-positive lymphocytes. This case showed the potential usefulness of patch testing in evaluating cases of toxic epidermal necrolysis. We believe that delayed hypersensitivity plays a crucial role in the development of druginduced toxic epidermal necrolysis. Furthermore, potential effector cells with phenotypic characteristics of CD8-positive lymphocytes (suppressor/cytotoxic T cells) seem to represent important mediators of the epidermal damage of the cutaneous lesion in our case.

(Arch Dermatol. 1991;127:851-855)



Author Affiliations

From the Department of Dermatology, Kansai Medical University, Osaka, Japan.


Footnotes

Accepted for publication November 6, 1990.

Reprint requests to Department of Dermatology, Kansai Medical University, 1 Fumizono-cho, Moriguchi, 570 Osaka, Japan (Dr Miyauchi).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Covalent Binding of the Nitroso Metabolite of Sulfamethoxazole Is Important in Induction of Drug-Specific T-Cell Responses in Vivo
Cheng et al.
Mol. Pharmacol. 2008;73:1769-1775.
ABSTRACT | FULL TEXT  

Association of Combined IL-13/IL-4R Signaling Pathway Gene Polymorphism with Stevens-Johnson Syndrome Accompanied by Ocular Surface Complications
Ueta et al.
IOVS 2008;49:1809-1813.
ABSTRACT | FULL TEXT  

Early pathological features of the cornea in toxic epidermal necrolysis
Williams et al.
Br J Ophthalmol 2007;91:1129-1132.
ABSTRACT | FULL TEXT  

Cell-Mediated Immunologic Mechanism and Severity of TEN
Faye et al.
Arch Dermatol 2005;141:775-776.
FULL TEXT  

Soluble Interleukin 2 Receptor and Interleukin 1{alpha} in Toxic Epidermal Necrolysis: A Comparative Analysis of Serum and Blister Fluid Samples
Correia et al.
Arch Dermatol 2002;138:29-32.
ABSTRACT | FULL TEXT  

Role of Delayed Cellular Hypersensitivity and Adhesion Molecules in Amoxicillin-Induced Morbilliform Rashes
Barbaud et al.
Arch Dermatol 1997;133:481-486.
ABSTRACT  

Characteristics of Toxic Epidermal Necrolysis in Patients Undergoing Long-term Glucocorticoid Therapy
Guibal et al.
Arch Dermatol 1995;131:669-672.
ABSTRACT  

Investigation of Mechanisms in Toxic Epidermal Necrolysis Induced by Carbamazepine
Friedmann et al.
Arch Dermatol 1994;130:598-604.
ABSTRACT  

Macrophages and Tumor Necrosis Factor {alpha} in Toxic Epidermal Necrolysis
Paquet et al.
Arch Dermatol 1994;130:605-608.
ABSTRACT  

Drug Rashes: What Are the Targets of Cell-Mediated Cytotoxicity?
Chosidow et al.
Arch Dermatol 1994;130:627-629.
ABSTRACT  

Abnormal T-Cell Response in Toxic Epidermal Necrolysis
Moncada et al.
Arch Dermatol 1994;130:116-116.
ABSTRACT  

Impaired Antigen Presentation in Toxic Epidermal Necrolysis
Bagot et al.
Arch Dermatol 1993;129:721-727.
ABSTRACT  

Cutaneous T-Cell Recruitment in Toxic Epidermal Necrolysis: Further Evidence of CD8+ Lymphocyte Involvement
Correia et al.
Arch Dermatol 1993;129:466-468.
ABSTRACT  

Two Cases of Transfusion-Associated Graft-vs-Host Disease After Open Heart Surgery
Tanaka et al.
Arch Dermatol 1992;128:1503-1506.
ABSTRACT  

Two Divergent Findings in TEN-Reply
Villada et al.
Arch Dermatol 1992;128:991-992.
ABSTRACT  

T-cell Subsets in Drug-Induced Toxic Epidermal Necrolysis
Hertl et al.
Arch Dermatol 1992;128:272-272.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.